Search Results - "Rupnow, Marcia F. T."

Refine Results
  1. 1

    Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients by Stokes, Michael E, Ye, Xin, Shah, Manan, Mercaldi, Katie, Reynolds, Matthew W, Rupnow, Marcia F T, Hammond, Jeffrey

    Published in BMC health services research (31-05-2011)
    “…Inadequate surgical hemostasis may lead to transfusion and/or other bleeding-related complications. This study examines the incidence and costs of…”
    Get full text
    Journal Article
  2. 2

    Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study by Munakata, Julie, Hazard, Elisabeth, Serrano, Daniel, Klingman, David, Rupnow, Marcia F.T., Tierce, Jonothan, Reed, Michael, Lipton, Richard B.

    Published in Headache (01-04-2009)
    “…Objective.— To evaluate the impact of incident transformed migraine on health care resource utilization, medication use, and productivity loss. In addition,…”
    Get full text
    Journal Article
  3. 3

    Cost-Effectiveness of a Potential Prophylactic Helicobacter pylori Vaccine in the United States by Rupnow, Marcia F. T., Chang, Alicia H., Shachter, Ross D., Owens, Douglas K., Parsonnet, Julie

    Published in The Journal of infectious diseases (15-10-2009)
    “…BackgroundHelicobacter pylori vaccines are under development to prevent infection. We quantified the cost-effectiveness of such a vaccine in the United States,…”
    Get full text
    Journal Article
  4. 4

    Residential Care/Assisted Living Staff May Detect Undiagnosed Dementia Using the Minimum Data Set Cognition Scale by Zimmerman, Sheryl, Sloane, Philip D., Williams, Christianna S., Dobbs, Debra, Ellajosyula, Ratnavalli, Braaten, Alyssa, Rupnow, Marcia F. T., Kaufer, Daniel I.

    “…OBJECTIVES: To estimate the sensitivity, specificity, and reliability of the Minimum Data Set Cognition Scale (MDS‐COGS) in screening for undetected dementia…”
    Get full text
    Journal Article
  5. 5

    Assessing and Managing All Aspects of Migraine: Migraine Attacks, Migraine-Related Functional Impairment, Common Comorbidities, and Quality of Life by Buse, Dawn C., Rupnow, Marcia F.T., Lipton, Richard B.

    Published in Mayo Clinic proceedings (01-05-2009)
    “…Migraine can be characterized as a chronic disorder with episodic attacks and the potential for progression to chronic migraine. We conducted a PubMed…”
    Get full text
    Journal Article
  6. 6

    The Impact of Topiramate on Health-Related Quality of Life Indicators in Chronic Migraine by Dodick, David W., Silberstein, Stephen, Saper, Joel, Freitag, Fred G., Cady, Roger K., Rapoport, Alan M., Mathew, Ninan T., Hulihan, Joseph, Crivera, Concetta, Rupnow, Marcia F.T., Mao, Lian, Finlayson, Gary, Greenberg, Steven J.

    Published in Headache (01-11-2007)
    “…Background.— Chronic migraine is a disabling primary chronic daily headache disorder that significantly impacts the daily activities of patients with this…”
    Get full text
    Journal Article
  7. 7

    Indirect Cost Burden of Migraine in the United States by Hawkins, Kevin, Wang, Sara, Rupnow, Marcia F. T.

    “…Objective: The purpose of this study was to determine the indirect cost burden associated with migraine. Methods: Data were obtained from Thomson-Medstat's…”
    Get full text
    Journal Article
  8. 8

    Validation of the Migraine-Specific Quality of Life Questionnaire Version 2.1 (Msq v. 2.1) for Patients Undergoing Prophylactic Migraine Treatment by Cole, Jason C., Lin, Peggy, Rupnow, Marcia F. T.

    Published in Quality of life research (01-09-2007)
    “…Objective Health-related quality of life (HRQoL) is an important outcome measure of migraine treatments. Although a number of migraine-specific HRQoL…”
    Get full text
    Journal Article
  9. 9

    Characterization of Type 2 Diabetes Mellitus Burden by Age and Ethnic Groups Based on a Nationwide Survey by Lopez, Janice M.S., PharmD, MPH, Bailey, Robert A., MD, Rupnow, Marcia F.T., PhD, Annunziata, Kathy, MA

    Published in Clinical therapeutics (01-04-2014)
    “…Abstract Background Type 2 diabetes mellitus (T2DM) is the most common form of diabetes. Risk factors for its development include older age, obesity, family…”
    Get full text
    Journal Article
  10. 10

    Electronic Medical Records as a Research Tool: Evaluating Topiramate Use at a Headache Center by Marmura, Michael J., Hopkins, Mary, Andrel, Jocelyn, Young, William B., Biondi, David M., Rupnow, Marcia F.T., Armstrong, Robert B.

    Published in Headache (01-05-2010)
    “…(Headache 2010;50:769‐778) Background.— Electronic medical records (EMRs) are used in large healthcare centers to increase efficiency and accuracy of…”
    Get full text
    Journal Article
  11. 11

    Topiramate in Migraine Prophylaxis: Long-Term Impact on Resource Utilization and Cost by Silberstein, Stephen D., Feliu, Anthony L., Rupnow, Marcia F.T., Blount, Angela C., Boccuzzi, Stephen J.

    Published in Headache (01-04-2007)
    “…Objective.—To evaluate the medical resource utilization and overall cost of care among patients treated with topiramate (TPM) for migraine prevention in a…”
    Get full text
    Journal Article
  12. 12

    Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis by Buysman, Erin K, Chow, Wing, Henk, Henry J, Rupnow, Marcia F T

    Published in BMC endocrine disorders (02-11-2015)
    “…Canagliflozin, an oral agent that inhibits sodium glucose co-transporter 2, improves glycemic control, body weight, and blood pressure and is generally well…”
    Get full text
    Journal Article
  13. 13

    The Burden of Migraine in the United States: Current and Emerging Perspectives on Disease Management and Economic Analysis by Hazard, Elisabeth, PhD, Munakata, Julie, MS, Bigal, Marcelo E., MD, PhD, Rupnow, Marcia F.T., PhD, Lipton, Richard B., MD

    Published in Value in health (2009)
    “…Abstract Objectives Migraine is often perceived as a low-impact condition that imposes a limited burden to society and the health-care system. This study…”
    Get full text
    Journal Article
  14. 14

    Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial by Gharabawi, Georges M, Greenspan, Andrew, Rupnow, Marcia F T, Kosik-Gonzalez, Colette, Bossie, Cynthia A, Zhu, Young, Kalali, Amir H, Awad, A George

    Published in BMC psychiatry (20-10-2006)
    “…Patient satisfaction with antipsychotic treatment is important. Limited evidence suggests that satisfaction is associated with symptom improvement and…”
    Get full text
    Journal Article
  15. 15

    Diabetes-Related Composite Quality End Point Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials by Bailey, Robert A., MD, Vijapurkar, Ujjwala, PhD, Meininger, Gary, MD, Rupnow, Marcia F.T., PhD, Blonde, Lawrence, MD

    Published in Clinical therapeutics (01-05-2015)
    “…Abstract Purpose This post hoc analysis evaluated attainment of diabetes-related composite quality measures (CQMs) with canagliflozin 100 mg, canagliflozin 300…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Persistence with Migraine Prophylactic Treatment and Acute Migraine Medication Utilization in the Managed Care Setting by Yaldo, Avin Z., PhD, Wertz, Debra A., PharmD, Rupnow, Marcia F.T., PhD, Quimbo, Ralph M., MA

    Published in Clinical therapeutics (01-12-2008)
    “…Abstract Objective: The aim of this study was to describe persistence with migraine prophylactic treatment and acute migraine medication utilization in…”
    Get full text
    Journal Article
  18. 18

    Evaluation of Resource Utilization and Cost Burden Before and After an Employer-Based Migraine Education Program by Page, Matthew J., Paramore, L. Clark, Doshi, Dilesh, Rupnow, Marcia F. T.

    “…Objectives: Study objectives were to determine the impact of migraine and severe headache on employer burden, resource utilization, and workplace productivity…”
    Get full text
    Journal Article
  19. 19

    Assessing the ability of topiramate to improve the daily activities of patients with migraine by Brandes, Jan Lewis, Kudrow, David B, Rothrock, John F, Rupnow, Marcia F T, Fairclough, Diane L, Greenberg, Steven J

    Published in Mayo Clinic proceedings (01-10-2006)
    “…To assess the impact of topiramate on the daily activities of patients with migraine. We performed a randomized, double-blind, placebo-controlled multicenter…”
    Get more information
    Journal Article
  20. 20

    Potential drug–drug interactions with antiepileptic drugs in Medicaid recipients by Dickson, Michael, Bramley, Thomas J, Kozma, Chris, Doshi, Dilesh, Rupnow, Marcia F T

    Published in American journal of health-system pharmacy (15-09-2008)
    “…The frequency of potential drug-drug interactions (DDIs) between antiepileptic drugs (AEDs) and other (non-AED) medications in Medicaid patients taking newer…”
    Get full text
    Journal Article